Clinical studies & Posters

Science icon

2024

Perceptual Learning Therapy Improves Vision & Contrast Sensitivity in Amblyopia Related with Post-CXL Keratoconus & MF-IOLs: Pooled Analysis

 

2024

Prospective Open-Label Randomized Controlled Clinical Study Evaluating the Efficacy of Perceptual Learning in Improving Vision among Patients with Congenital Nystagmus – AAPOS 2024

 

2024

ASCRS 2024 Best Poster Award: RCT Results of Perceptual Amblyopia Therapy for Improving Vision & Contrast Sensitivity Functions in Crosslinked Stable Keratoconus

 

2023

AAPOS 2023: Improving Vision and Binocularity in Older Children and Adults with Amblyopia and Nystagmus

 

2011

AAO 2011: Two – Year Results of NeuroVision Treatment in Adult Patients with Unilateral Amblyopia


2011

Visual Acuity and Contrast Sensitivity Improvement in Cases of Congenital Nystagmus Using NeuroVision™ (RevitalVision LLC.) Technology: A Retrospective Multinational Multicenter Case Series. 2011.

 

2011

Case Report: 83 Year Old Wet AMD Patient Successfully Treated with NeuroVision (RevitalVision LLC.)

 

2011

ESCRS: Efficacy of neural vision therapy to enhance visual acuity and contrast sensitivity function in Amblyopia

 

2010

ARVO: Evaluation of Computer-Based Primary Visual Cortex Training After Aspheric Monofocal, Multifocal, and Accommodating IOL Implantation 

 

2009

ASCRS: Neuroplasticity Key to Vision Recovery – efficacy in improving vision in patients with Retinitis Pigmentosa (RP), Keratoconus patients following intra-stromal corneal ring, and following cataract surgery with Multi-Focal IOL replacement.

 

2008

AAO: NeuroVision treatment of unilateral Amblyopia in patients older than 9 years

 

2008

AAO: A randomized controlled trial evaluating the efficacy of neurovision’s neural vision correction technology in enhancing unaided visual acuity in adults with Low Myopia

 

2008

IMC: 2 Years follow-up results of visual acuity and contrast sensitivity enhancement in patients with Low Myopia using NeuroVision neural vision correction technology

 

2007

ASIA ARVO: Cortical enhancement of Habitual VA of subjects using Neural Vision Correction Technology

 

2007

AAO: A randomized controlled trial evaluating the efficacy of neural vision correction technology in enhancing unaided visual acuity in Low Myopes

 

2007

ARVO: Enhancement of undercorrected visual acuity and contrast sensitivity in Myopic Children using NeuroVision’s neural vision correction technology

 

2006

APAO: Improving VA and CSF in subjects with low degree of Myopia and early Presbyopia using neural vision correction technology

 

2005

AAO: What is still lacking in Refractive Surgery is the role of neuroprocessing

 

2005

ASIA ARVO: The alternative approach to visual blur: NeuroVision treatment for Myopia, Post-Refractive Surgery and Presbyopia

 

2005

ARVO: Improving CSF in subjects with a Low degree of Myopia using neural vision correction technology

 

2004

ARVO: Pilot study to evaluate the efficacy of neural vision correction technology for vision improvement in Low Myopia

 

Contact Us



    Talshir Medical Technologies LTD
    USA Office: 1.800.361.8218 | Main Office: +972.77.212.3272

    info@revitalvision.com
    Contact background